• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Nature clinical practice. Rheumatology >Screening for osteoporosis in men: comment on the American College of Physicians clinical guidelines
【24h】

Screening for osteoporosis in men: comment on the American College of Physicians clinical guidelines

机译：筛查男性骨质疏松症：评论美国医师学院临床指南

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Osteoporosis is an important clinical problem in men. Men who sustain a hip fracture have excess mortality for up to 2 years following the fracture, and those who survive beyond this period of time are likely to have long-term functional impairment that can result in physical disability as well as increased risk for a second hip fracture.1 Prevention of hip and other osteoporotic fractures in men requires both the identification of those at risk for fracture and the availability of effective treatments to reduce fracture risk. Given that low bone mineral density (BMD) is a major risk factor for hip and other osteoporotic fractures in men as well as women,2'3 it is important to identify those men with osteoporosis or the combination of low BMD and clinical risk factors that portend a clinically important risk of fracture in the foreseeable future.
机译：骨质疏松症是男性的重要临床问题。患有髋部骨折的男性在骨折后长达2年的死亡率过高，而那些存活时间超过此期限的男性则可能会长期遭受功能障碍，这可能导致身体残疾并增加第二次患病的风险。髋部骨折。1要预防男性髋部和其他骨质疏松性骨折，既要确定有骨折风险的人，又要有降低骨折风险的有效治疗方法。鉴于低骨密度是男性和女性髋部和其他骨质疏松性骨折的主要危险因素，2'3，因此重要的是要识别出那些患有骨质疏松症或低骨密度与临床危险因素相结合的男性。在可预见的将来预示着临床上重要的骨折风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号